Paiktis is a hairy fooker.
Announcement
Collapse
No announcement yet.
science for GP
Collapse
X
-
Originally posted by Ecthy
Because they're afraid of their own intelligence and imagination. They hate anything that is not conform with their standardized world. And this is not a freak speaking, I do fit well into most social environments and all, but I do keep an open mind for things, which maths people just don't.Speaking of Erith:
"It's not twinned with anywhere, but it does have a suicide pact with Dagenham" - Linda Smith
Comment
-
Originally posted by DrS
Is nanotech the first step towards the patenting of matter?
Actually, could you explain how a large surface area to volume ratio aids in catalysis?
If you break up the clump though the surface area will increase drastically, and the solid/liquid interface with it. Basically there's more chance of colisions happening so it will go faster.
Comment
-
Yeah, it's all about maximising surface area giving a greater capacity to catalyse. This form of catalysis works on the basis of adsorption, so the more surface area you have, the more reaction sites you have, therefore, the quicker the reaction proceeds...Speaking of Erith:
"It's not twinned with anywhere, but it does have a suicide pact with Dagenham" - Linda Smith
Comment
-
HIV Turns Off Immune Cells
E-mail Print Link RSS del.icio.us Digg
Image: FROM LAWRENCE BERKELEY NATIONAL LABORATORY
HIV appears to wear out the immune system. Killer T cells that would typically proliferate to ward off an infection instead languish under the HIV onslaught. Two independent teams of researchers have uncovered the cause of this failure, tracing it to a particular molecular pathway known as Programmed Death-1, or PD-1.
Earlier research by Rafi Ahmed of Emory University found that such viral infections in mice stall the innate immune response by flicking on the PD-1 switch, which keeps the T cells from functioning. Furthermore, by blocking that switch, his team could restore the T cells to the fight and reduce the amount of virus in the infected mice. Such findings inspired Bruce Walker of Harvard Medical School and his team to investigate the PD-1 pathway in humans.
ADVERTISEMENT (article continues below)
The researchers focused on untreated individuals in Durban, South Africa, an area in the grips of an AIDS crisis where more than 30 percent of its population--and 50 percent of pregnant women--are infected. They found that the immune cells of 71 HIV-infected subjects had elevated levels of PD-1 expression compared to uninfected controls. The afflicted cells proved unable to function in the presence of HIV and thus the subjects had higher overall levels of the virus. "It's long been known that people with HIV infection have a lot of HIV-specific immune cells that one would think would be actively combating the virus," Walker says. "But a major puzzle has been that even in late stage illness, when one can still measure great numbers of these immune cells, they don't seem to be controlling the virus at all." A research team led by Rafick-Pierre Sekaly of the University of Montreal found similar correlations in a paper published yesterday in Nature Medicine.
Blood samples from four patients taken both before and after they began antiretroviral therapy revealed that PD-1 expression dropped in the wake of treatment in the Walker study. And by actively blocking the PD-1 pathway the researchers were able to boost the numbers of HIV-fighting immune cells in the samples. "We wanted to determine whether these T cells had been irreparably damaged or misprogrammed," Walker explains. "And we found that they are capable of functioning, they've just been turned off."
"The majority of patients we have studied had no detectable levels of these HIV-specific cells, but as soon as we blocked the PD-1 pathway, they had a ton of them," he continues. This does not mean, however, that a new treatment for AIDS is at hand, the authors warn in the paper presenting the finding, which was published online by Nature yesterday. Although drugs to block the PD-1 pathway have been developed for cancer patients, they affect all immune cells, not just HIV-specific ones. "If you turn back on an immune regulatory switch that the body has decided to turn off," Walker cautions, "you could trigger serious immunological problems." --David BielloWe need seperate human-only games for MP/PBEM that dont include the over-simplifications required to have a good AI
If any man be thirsty, let him come unto me and drink. Vampire 7:37
Just one old soldiers opinion. E Tenebris Lux. Pax quaeritur bello.
Comment
-
Yeah, it's all about maximising surface area giving a greater capacity to catalyse. This form of catalysis works on the basis of adsorption, so the more surface area you have, the more reaction sites you have, therefore, the quicker the reaction proceeds...
Our CFN guys are always talking about how nanostructures could act as wonderful catalysts, but I haven't studied chemistry since high school... and badly then.
Comment
-
I also never quite understood why carbon nanotubes were hailed as possible heat sinks for microcircuitry. I can see thermal conduction along the 1-d tube axis, but off that axis (even just a bit), it would seem (naively?) like an insulator. *shrug*
Comment
Comment